Project Number 5R03AG063235-02 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Pyroglutamate-modified Amyloid-B protein as a marker for future cognitive decline in preclinical Alzheimer’s disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers e. Multi-fluid Biomarkers Researcher and Organization Principal Investigator AYYAPPAN PILLAI, JAGAN Principal Investigator First Name JAGAN Principal Investigator Last Name AYYAPPAN PILLAI Awardee Organization CLEVELAND CLINIC LERNER COM-CWRU Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-19-002: Small Research Grant Program for the Next Generation of Clinical Researchers in Alzheimer's Disease (AD) and Alzheimers Disease Related Dementias (ADRD) Research (R03 Clinical Trial Optional) FY Overall Cost $160,750 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official LUO, YUAN
